gip glp-1 dual agonist GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Understand GLP-1/GIP Dual Agonist Tirzepatide

Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk

Soon after this, in 1907, MA Lane, at the University of Chicago, observed two sets of cells stained differently in the pancreatic islets which he called 'alpha' (A) and 'beta' (B) (Lane)

Reusing needles can introduce bacteria, cause unnecessary pain, and may even damage the pen

SIRT1 can deacetylate LKB1, an upstream regulator of AMPK, increasing the cytoplasmic localization of LKB1 and thus promoting AMPK activation

Early weight loss with liraglutide 3.0 mg predicts 1-year weight loss and is associated with improvements in clinical markers

Its not just that I was less hungryit felt like a switch had flipped in my brain, the same switch that drives addictive behaviors